West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,800 | 20,900 | 61,500 | 54,000 | 68,800 |
| Receivables | 110,500 | 104,800 | 103,300 | 84,300 | 75,100 |
| Inventories | 71,100 | 64,700 | 64,600 | 62,500 | 56,700 |
| Income taxes - deferred | 2,400 | 7,600 | 7,100 | 7,100 | 8,200 |
| Other current assets | 14,300 | 19,800 | 19,200 | 15,100 | 17,700 |
| TOTAL | $247,100 | $217,800 | $255,700 | $223,000 | $226,500 |
| Non-Current Assets | |||||
| PPE Net | 328,000 | 322,200 | 318,500 | 277,500 | 283,800 |
| Investments And Advances | 27,700 | 26,700 | 27,200 | 27,200 | 26,600 |
| Intangibles | 159,200 | 162,800 | 107,600 | 45,400 | 43,700 |
| Other Non-Current Assets | 71,500 | 70,000 | 88,800 | 76,900 | 68,600 |
| TOTAL | $586,400 | $581,700 | $542,100 | $427,000 | $422,700 |
| Total Assets | $833,500 | $799,500 | $797,800 | $650,000 | $649,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 45,800 | 35,400 | 34,400 | 23,400 | 29,300 |
| Accrued Expenses | 81,200 | 51,700 | 48,500 | 45,800 | 76,500 |
| Other current liabilities | 1,000 | 35,100 | 28,900 | 29,100 | N/A |
| TOTAL | $128,300 | $122,600 | $113,200 | $99,000 | $116,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 280,700 | 260,200 | 277,300 | 152,700 | 150,800 |
| aiOther Non-Current Liabilities | 52,700 | 52,000 | 46,200 | 45,800 | 45,300 |
| TOTAL | $365,300 | $351,500 | $369,200 | $243,300 | $231,600 |
| Total Liabilities | $493,600 | $474,100 | $482,400 | $342,300 | $348,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,003 | 63,439 | 63,135 | 62,183 | 61,972 |
| Common Shares | 8,600 | 8,600 | 8,600 | 8,600 | 8,600 |
| Retained earnings | 325,000 | 310,600 | 306,600 | 297,400 | 287,500 |
| Other shareholders' equity | 9,000 | 12,100 | 13,100 | 27,000 | 36,500 |
| TOTAL | $339,900 | $325,400 | $315,400 | $307,700 | $301,100 |
| Total Liabilities And Equity | $833,500 | $799,500 | $797,800 | $650,000 | $649,200 |